48,830
edits
Difference between revisions of "MOC31"
Jump to navigation
Jump to search
no edit summary
(create) |
|||
| Line 5: | Line 5: | ||
==Negative== | ==Negative== | ||
*[[Hepatocellular carcinoma]].<ref name=pmid10937059/> | *[[Hepatocellular carcinoma]].<ref name=pmid10937059/> | ||
*[[Malignant mesothelioma|Malignant epithelioid mesothelioma]] - usually negative.<ref name=pmid9490276/> | |||
==Positive== | ==Positive== | ||
*[[Cholangiocarcinoma]].<ref name=pmid10937059/> | *[[Cholangiocarcinoma]].<ref name=pmid10937059/> | ||
*[[Liver metastases]].<ref name=pmid10937059/> | *[[Liver metastases]].<ref name=pmid10937059/> | ||
*[[Lung adenocarcinoma]].<ref name=pmid9490276>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. | journal = Hum Pathol | volume = 29 | issue = 2 | pages = 166-9 | month = Feb | year = 1998 | doi = | PMID = 9490276 }}</ref> | |||
==See also== | ==See also== | ||